Syncom Formulations (India) Limited (BOM:524470)

Market Cap	11.48B
Revenue (ttm)	5.15B
Net Income (ttm)	630.52M
Shares Out	940.00M
EPS (ttm)	0.63
PE Ratio	19.52
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	201,699
Average Volume	214,018
Open	11.85
Previous Close	11.76
Day's Range	11.52 - 12.39
52-Week Range	11.52 - 23.46
Beta	0.67
RSI	25.40
Earnings Date	Feb 14, 2026

About BOM:524470

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, an...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 744
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524470

Financial Performance

In 2024, BOM:524470's revenue was 4.65 billion, an increase of 76.55% compared to the previous year's 2.63 billion. Earnings were 494.35 million, an increase of 95.28%.